Publikationen, an denen er mitarbeitet Maria Luisa Lozano Almela (29)

2024

  1. miR-146a−/− mice model reveals that NF-κB inhibition reverts inflammation-driven myelofibrosis-like phenotype

    American Journal of Hematology, Vol. 99, Núm. 7, pp. 1326-1337

2022

  1. MiR-146a Contributes to Thromboinflammation and Recurrence in Young Patients with Acute Myocardial Infarction

    Journal of Personalized Medicine, Vol. 12, Núm. 7

2020

  1. Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonists

    Thrombosis Research, Vol. 185, pp. 119-124

  2. Platelet activation and neutrophil extracellular trap (NET) formation in immune thrombocytopenia: is there an association?

    Platelets, Vol. 31, Núm. 7, pp. 906-912

2019

  1. MicroRNAs as potential regulators of platelet function and bleeding diatheses

    Platelets, Vol. 30, Núm. 7, pp. 803-808

2009

  1. Genotype-phenotype relationship for six common polymorphisms in genes affecting platelet function from 286 healthy subjects and 160 patients with mucocutaneous bleeding of unknown cause

    British Journal of Haematology, Vol. 146, Núm. 1, pp. 95-103

2007

  1. Latent and polymeric antithrombin: Clearance and potential thrombotic risk

    Experimental Biology and Medicine, Vol. 232, Núm. 2, pp. 219-226

  2. The association of the β1-tubulin Q43P polymorphism with intracerebral hemorrhage in men

    Haematologica, Vol. 92, Núm. 4, pp. 513-518

2003

  1. The -1C>T mutation in the annexin A5 gene does not affect plasma levels of annexin A5 [2] (multiple letters)

    Blood

2002

  1. A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients

    Blood, Vol. 100, Núm. 6, pp. 2081-2086

  2. Platelet aggregation through prothrombinase activation induced by non-aggregant doses of platelet agonists

    Blood Coagulation and Fibrinolysis, Vol. 13, Núm. 2, pp. 95-103

2001

  1. Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation

    Thrombosis and Haemostasis, Vol. 85, Núm. 4, pp. 686-693

  2. Polymorphisms of P-selectin glycoprotein ligand-1 are associated with neutrophil-platelet adhesion and with ischaemic cerebrovascular disease

    British Journal of Haematology, Vol. 115, Núm. 4, pp. 969-976

  3. Protocolo terapéutcio y criterios de ingreso hospitalario de pacientes con alteraciones en la hemostasia

    Medicine: Programa de Formación Médica Continuada Acreditado, Vol. 8, Núm. 53, pp. 2859-2862

2000

  1. A common polymorphism flanking the ATG initiator codon of GPIbα does not affect expression and is not a major risk factor for arterial thrombosis

    Thrombosis and Haemostasis, Vol. 83, Núm. 1, pp. 23-28

  2. Evaluation of pooled platelet concentrates using prestorage versus poststorage WBC reduction: Impact of filtration timing

    Transfusion, Vol. 40, Núm. 7, pp. 781-788

  3. Platelet GP Ib/IX/V complex: Physiological role

    Journal of Physiology and Biochemistry, Vol. 56, Núm. 4, pp. 355-365

  4. The TFPI 536C→T mutation is not associated with increased risk for venous or arterial thrombosis

    Thrombosis and Haemostasis

1999

  1. Platelet cryopreservation using a reduced dimethyl sulfoxide concentration and second-messenger effectors as cryopreserving solution

    Cryobiology, Vol. 39, Núm. 1, pp. 1-12

  2. Quality assessment of platelet concentrates supplemented with second- messenger effectors

    Transfusion, Vol. 39, Núm. 2, pp. 135-143